Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Artificial Intelligence In Cancer Diagnostics Market Growth Potential: How Will Market Size Shift Through 2030?
The artificial intelligence in cancer diagnostics market has experienced substantial growth in recent years. It is forecast to increase from $0.52 billion in 2025 to $0.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 31.3%. The historical expansion of this market can be attributed to factors such as the increasing volume of medical imaging data, the initial adoption of computer-aided diagnosis, a rise in cancer prevalence, advances in imaging technologies, and greater digitization within healthcare.
The artificial intelligence in cancer diagnostics market is set to experience significant growth in the upcoming years. It is forecasted to expand to $2.02 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 30.9%. This expansion during the forecast period is propelled by factors such as the increasing need for early cancer detection, the wider adoption of precision medicine, improvements in diagnostic accuracy driven by AI, greater funding for oncology research, and the consolidation of genomics and imaging data. Prominent developments expected over this period include AI-assisted medical imaging analysis, an increase in tools for early cancer detection, the incorporation of predictive oncology analytics, the automation of diagnostic workflows, and a growing acceptance of decision support systems.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Intelligence In Cancer Diagnostics Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The increasing occurrence of cancer is anticipated to drive the expansion of artificial intelligence within the cancer diagnostics market. Cancer is characterized by uncontrolled cell proliferation, affecting multiple organs and leading to considerable illness and fatalities globally. Artificial intelligence finds application in cancer diagnostics, facilitating accurate and efficient examination of medical imaging data, thereby assisting in the prompt identification and precise categorization of cancerous lesions. For instance, the American Cancer Society, a US-based non-profit organization, estimated in January 2025 that the United States would see 2,041,910 new cancer cases and 618,120 cancer deaths in 2025. Additionally, the World Health Organisation, a Switzerland-based intergovernmental organization, reported in February 2024 that around 20 million new cancer cases were identified in 2022, resulting in 9.7 million deaths, with an estimated 53.5 million individuals surviving within five years after receiving a cancer diagnosis. Consequently, the increasing incidence of cancer is projected to fuel the expansion of artificial intelligence in the cancer diagnostics market.
Artificial Intelligence In Cancer Diagnostics Market Segment Performance And Emerging Opportunities
The artificial intelligence in cancer diagnostics market covered in this report is segmented –
1) By Component: Software Solutions, Hardware, Services
2) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Types
3) By Application: Screening And Diagnosis, Tumor Identification, Surveillance, Treatment
4) By End-User: Hospitals, Medical Research Institute, Diagnostic Centers, Contract Research Organization
Subsegments:
1) By Software Solutions: Imaging Analysis Software, Predictive Analytics Software, Decision Support Systems, Data Management Platforms
2) By Hardware: Imaging Devices, Biomarkers Detection Equipment, Computing Infrastructure
3) By Services: Consulting Services, Implementation Services, Maintenance And Support Services, Training Services
Artificial Intelligence In Cancer Diagnostics Market Innovation Trends Shaping Future Development
Companies operating within the artificial intelligence in cancer diagnostics market are prioritizing strategic collaborations to accelerate the adoption of AI-powered digital pathology technologies for enhancing cancer diagnosis. Such partnerships involve organizations combining their strengths and resources to attain mutual advantages and success. As an illustration, in October 2023, F. Hoffmann-La Roche AG, a Switzerland-based diagnostics and pharmaceutical firm, revealed a partnership involving Ibex Medical Analytics, an Israeli medical technology company, and Amazon Web Services, Inc., a US-based comprehensive cloud provider. This collaboration aims to allow pathology laboratories to use the navify Digital Pathology software platform, thereby gaining access to Ibex’s AI-driven decision support functionalities to assist medical professionals in diagnosing breast and prostate cancer. The joint effort between Ibex Medical Analytics and Roche is producing innovative AI-powered procedures designed to help pathologists and laboratories fully achieve the potential of digital transformation. These cloud-based digital pathology and AI solutions from Roche and Ibex operate on Amazon Web Services (AWS), providing a scalable and enduring environment for pathology laboratories.
Artificial Intelligence In Cancer Diagnostics Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the artificial intelligence in cancer diagnostics market are Microsoft Corporation; Siemens; Roche Holding AG; Google LCC; International Business Machines Corporation; Thermo Fisher Scientific Inc.; Illumina Inc.; Bio Rad Laboratories Inc.; Flatiron Health; Tempus Labs Inc.; Paige AI Inc.; OncoHealth Corporation; Path AI Inc.; Aidoc; Sophia Genetics SA; Digital Diagnostics Inc.; Prognos Health; Aidence; Kheiron Medical Technologies Limited; Zebra Medical Vision; Niramai; Enlitic Inc.; Therapixel; Medial EarlySign Ltd.; Freenome; SkinVision B.V.
View The Full Artificial Intelligence In Cancer Diagnostics Market Report:
Artificial Intelligence In Cancer Diagnostics Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the artificial intelligence in cancer diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cancer diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
